Positive Trial Results Released for Alpha-1 Antitrypsin Deficiency-Associated Emphysema Treatment
Mereo BioPharma Group has just announced positive results from their Phase 2 study called ASTRAEUS. This study investigated alvelestat (MPH-966), which is an oral neutrophil elastase inhibitor, as a treatment…